Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q60156355)
Watch
English
Activity of the herbal combination, PC-SPES, in the treatment of patients with androgen-independent prostate cancer
article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
11164156
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11164156%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 November 2019
title
Activity of the herbal combination, PC-SPES, in the treatment of patients with androgen-independent prostate cancer
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
11164156
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11164156%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 November 2019
main subject
prostate cancer
1 reference
based on heuristic
inferred from title
author
William K. Oh
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
11164156
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11164156%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 November 2019
Philip W. Kantoff
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed publication ID
11164156
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11164156%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 November 2019
author name string
D J George
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
11164156
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11164156%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 November 2019
K Hackmann
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed publication ID
11164156
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11164156%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 November 2019
J Manola
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed publication ID
11164156
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11164156%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 November 2019
language of work or name
English
0 references
publication date
1 January 2001
1 reference
stated in
Europe PubMed Central
PubMed publication ID
11164156
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11164156%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 November 2019
published in
Urology
1 reference
stated in
Europe PubMed Central
PubMed publication ID
11164156
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11164156%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 November 2019
volume
57
1 reference
stated in
Europe PubMed Central
PubMed publication ID
11164156
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11164156%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 November 2019
issue
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
11164156
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11164156%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 November 2019
page(s)
122-126
1 reference
stated in
Europe PubMed Central
PubMed publication ID
11164156
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11164156%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 November 2019
cites work
Clinical and biologic activity of an estrogenic herbal combination (PC-SPES) in prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900986-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effects of a phytotherapeutic agent, PC-SPES, on prostate cancer: a preliminary investigation on human cell lines and patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900986-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
PC-SPES: a unique inhibitor of proliferation of prostate cancer cells in vitro and in vivo .
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900986-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Use of PC-SPES, a commercially available supplement for prostate cancer, in a patient with hormone-naive disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900986-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
MANAGEMENT OF HORMONE REFRACTORY PROSTATE CANCER: CURRENT STANDARDS AND FUTURE PROSPECTS
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900986-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer: recommendations from the Prostate-Specific Antigen Working Group.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900986-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Individual Comparisons by Ranking Methods
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900986-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Nonparametric Estimation from Incomplete Observations
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900986-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
PC-SPES, a dietary supplement for the treatment of hormone-refractory prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900986-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A phase II trial of oral diethylstilbesterol as a second-line hormonal agent in advanced prostate cancer.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900986-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Low-dose continuous oral fosfestrol is highly active in 'hormone-refractory' prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900986-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Mechanisms of action and clinical uses of estramustine
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900986-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0090-4295(00)00986-9
1 reference
stated in
Europe PubMed Central
PubMed publication ID
11164156
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11164156%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 November 2019
PubMed publication ID
11164156
1 reference
stated in
Europe PubMed Central
PubMed publication ID
11164156
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11164156%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 November 2019
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
